These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 38193030)

  • 1. Tenecteplase for the treatment of acute ischemic stroke in the extended time window: a systematic review and meta-analysis.
    Palaiodimou L; Katsanos AH; Turc G; Romoli M; Theodorou A; Lemmens R; Sacco S; Velonakis G; Vlachopoulos C; Tsivgoulis G
    Ther Adv Neurol Disord; 2024; 17():17562864231221324. PubMed ID: 38193030
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tenecteplase vs Alteplase in Acute Ischemic Stroke Within 4.5 Hours: A Systematic Review and Meta-Analysis of Randomized Trials.
    Palaiodimou L; Katsanos AH; Turc G; Asimakopoulos AG; Mavridis D; Schellinger PD; Theodorou A; Lemmens R; Sacco S; Safouris A; Katan M; Sarraj A; Fischer U; Tsivgoulis G
    Neurology; 2024 Nov; 103(9):e209903. PubMed ID: 39413337
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The efficacy and safety of intravenous thrombolysis with tenecteplase versus alteplase for acute ischemic stroke: a systematic review and meta-analysis.
    Wei H; Fu B; Yang C; Huang M
    Neurol Sci; 2023 Sep; 44(9):3005-3015. PubMed ID: 37061572
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and safety outcomes of Tenecteplase versus Alteplase for thrombolysis of acute ischemic stroke: A meta-analysis of 9 randomized controlled trials.
    Wang Y; Cai X; Fang Q; Zhu J
    J Neurol Sci; 2024 Mar; 458():122912. PubMed ID: 38325064
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative efficacy and safety among different doses of tenecteplase for acute ischemic stroke: A systematic review and network meta-analysis.
    Srisurapanont K; Uawithya E; Dhanasomboon P; Pollasen N; Thiankhaw K
    J Stroke Cerebrovasc Dis; 2024 Aug; 33(8):107822. PubMed ID: 38897370
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The efficacy and safety of tenecteplase versus alteplase for acute ischemic stroke: an updated systematic review, pairwise, and network meta-analysis of randomized controlled trials.
    Abuelazm M; Seri AR; Awad AK; Ahmad U; Mahmoud A; Albazee E; Kambalapalli S; Abdelazeem B
    J Thromb Thrombolysis; 2023 Feb; 55(2):322-338. PubMed ID: 36449231
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tenecteplase versus alteplase for patients with acute ischemic stroke: a meta-analysis of randomized controlled trials.
    Zhang X; Wan TF; Chen J; Liu L
    Aging (Albany NY); 2023 Dec; 15(24):14889-14899. PubMed ID: 38149983
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and Safety of Intravenous Tenecteplase Bolus in Acute Ischemic Stroke: Results of Two Open-Label, Multicenter Trials.
    Ramakrishnan TCR; Kumaravelu S; Narayan SK; Buddha SS; Murali C; Majeed PHA; Meenakshi-Sundaram S; Wadia RS; Sharma V; Basu I; Vijaya P; Salam KA; Barmare S; Vaid Z; Nirmal Raj KK; Wattamwar PR; Asokan K; Dhonge V; Nellikunja S; Namjoshi D; Srinivasa R; Laddhad DS; Deshpande SD; Raghunath B; Kalita J; Kumar M; Misra UK; Pradeep M;
    Am J Cardiovasc Drugs; 2018 Oct; 18(5):387-395. PubMed ID: 29948822
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tenecteplase vs. alteplase for treatment of acute ischemic stroke: A systematic review and meta-analysis of randomized trials.
    Kobeissi H; Ghozy S; Turfe B; Bilgin C; Kadirvel R; Kallmes DF; Brinjikji W; Rabinstein AA
    Front Neurol; 2023; 14():1102463. PubMed ID: 36756249
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Off-Label Use of Tenecteplase for the Treatment of Acute Ischemic Stroke: A Systematic Review and Meta-analysis.
    Katsanos AH; Psychogios K; Turc G; Sacco S; de Sousa DA; De Marchis GM; Palaiodimou L; Filippou DK; Ahmed N; Sarraj A; Menon BK; Tsivgoulis G
    JAMA Netw Open; 2022 Mar; 5(3):e224506. PubMed ID: 35357458
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intravenous Tenecteplase for Acute Ischemic Stroke Within 4.5-24 Hours of Onset (ROSE-TNK): A Phase 2, Randomized, Multicenter Study.
    Wang L; Dai YJ; Cui Y; Zhang H; Jiang CH; Duan YJ; Zhao Y; Feng YF; Geng SM; Zhang ZH; Lu J; Zhang P; Zhao LW; Zhao H; Ma YT; Song CG; Zhang Y; Chen HS
    J Stroke; 2023 Sep; 25(3):371-377. PubMed ID: 37608533
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety and Efficacy of Tenecteplase and Alteplase in Patients With Tandem Lesion Stroke: A Post Hoc Analysis of the EXTEND-IA TNK Trials.
    Yogendrakumar V; Churilov L; Mitchell PJ; Kleinig TJ; Yassi N; Thijs V; Wu T; Shah D; Bailey P; Dewey HM; Choi PMC; Ma A; Wijeratne T; Garcia-Esperon C; Cloud G; Chandra RV; Cordato DJ; Yan B; Sharma G; Desmond PM; Parsons MW; Donnan GA; Davis SM; Campbell BCV;
    Neurology; 2023 May; 100(18):e1900-e1911. PubMed ID: 36878701
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety and Efficacy of Tenecteplase in Older Patients With Large Vessel Occlusion: A Pooled Analysis of the EXTEND-IA TNK Trials.
    Yogendrakumar V; Churilov L; Mitchell PJ; Kleinig TJ; Yassi N; Thijs V; Wu TY; Shah DG; Ng FC; Dewey HM; Wijeratne T; Yan B; Desmond PM; Parsons MW; Donnan GA; Davis SM; Campbell BCV;
    Neurology; 2022 Mar; 98(12):e1292-e1301. PubMed ID: 35017305
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence that Tenecteplase Is Noninferior to Alteplase for Acute Ischemic Stroke: Meta-Analysis of 5 Randomized Trials.
    Burgos AM; Saver JL
    Stroke; 2019 Aug; 50(8):2156-2162. PubMed ID: 31318627
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endovascular treatment for large-core ischaemic stroke: a meta-analysis of randomised controlled clinical trials.
    Palaiodimou L; Sarraj A; Safouris A; Magoufis G; Lemmens R; Sandset EC; Turc G; Psychogios M; Tsivgoulis G
    J Neurol Neurosurg Psychiatry; 2023 Oct; 94(10):781-785. PubMed ID: 37451694
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tenecteplase versus Alteplase in Acute Ischemic Stroke: A Systematic Review and Meta-analysis.
    Singh A; Singh MP; Gaikwad NR; Kannauje PK
    Ann Neurosci; 2024 Apr; 31(2):132-142. PubMed ID: 38694719
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intravenous Thrombolysis with Tenecteplase for the Treatment of Acute Ischemic Stroke.
    Tsivgoulis G; Katsanos AH; Christogiannis C; Faouzi B; Mavridis D; Dixit AK; Palaiodimou L; Khurana D; Petruzzellis M; Psychogios K; Macleod MJ; Ahmed N
    Ann Neurol; 2022 Sep; 92(3):349-357. PubMed ID: 35713213
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tenecteplase Plus Butyphthalide for Stroke Within 4.5-6 Hours of Onset (EXIT-BT): a Phase 2 Study.
    Chen HS; Chen MR; Cui Y; Shen XY; Zhang H; Lu J; Zhao LW; Duan YJ; Li J; Wang YM; Min LQ; Zhao LH; Wan LS; Zhang ZH; Nguyen TN
    Transl Stroke Res; 2024 Jan; ():. PubMed ID: 38238620
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intravenous tenecteplase for acute ischemic stroke between 4.5 and 6 h of onset (EXIT-BT2): Rationale and Design.
    Wang YH; Guo ZN; Chen MR; Yao ZG; Nguyen TN; Saver JL; Yang Y; Chen HS
    Eur Stroke J; 2024 Jun; ():23969873241258058. PubMed ID: 38859581
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.